We are proud to announce that APICES has been acknowledged for its ongoing collaboration in the BEATcc study, an International (EU, USA, APAC) Phase III clinical trial in cervical cancer. This acknowledgement was highlighted during an oral presentation…
We want to share the acknowledgment that APICES has received in ORIGEN study, which is a NSCLC retrospective study, published in the ESMO 2023 congress, in which APICES has collaborated in start-up, project management, monitoring, biostatistics, and medical…
The ESMO 2024 congress in Barcelona united the global Oncology community to discuss the latest breakthroughs in cancer research. APICES, as a CRO with 15 years of experience in Oncology clinical trials, we were honored to be part…
Our team at APICES CRO will be attending the ESMO Congress 2024 in Barcelona from September 13th to 17th!
